More about

Mcmaster University

News
February 18, 2023
1 min read
Save

Poor control of CVD risk factors common in men with prostate cancer

Poor control of CVD risk factors common in men with prostate cancer

Men with prostate cancer are likely to have poor control of modifiable CV risk factors, according to study findings published in JACC: CardioOncology.

News
January 03, 2023
2 min read
Save

Persistent positive ANA tests 1 year after COVID-19 may predict long COVID symptoms

Persistent positive ANA tests 1 year after COVID-19 may predict long COVID symptoms

Consistently positive antinuclear antibody tests at 12 months following acute SARS-CoV-2 infection may predict long-term symptoms and inflammation, according to data published in the European Respiratory Journal.

News
December 15, 2022
2 min read
Save

Nearly 25% of children with type 2 diabetes do not have obesity

Nearly 25% of children with type 2 diabetes do not have obesity

Obesity was not a universal phenotype among children with type 2 diabetes, despite being an important risk factor, according to a systematic review and meta-analysis published in JAMA Network Open.

News
November 13, 2022
2 min read
Save

No cancer risk seen with topical calcineurin inhibitors for atopic dermatitis

No cancer risk seen with topical calcineurin inhibitors for atopic dermatitis

LOUISVILLE, Ky. — Researchers showed with moderate certainty that topical calcineurin inhibitors did not increase cancer risk when used as a treatment for atopic dermatitis among infants, children and adults, according to study results.

News
October 26, 2022
1 min read
Save

Aqueous povidone-iodine or chlorhexidine gluconate may be effective for skin antisepsis

Aqueous povidone-iodine or chlorhexidine gluconate may be effective for skin antisepsis

TAMPA, Fla. — According to presented results, skin antisepsis for surgical site infection in patients undergoing surgery for an open fracture was effective with both aqueous 10% povidone-iodine and aqueous 4% chlorhexidine gluconate.

News
September 20, 2022
2 min read
Save

Better criteria, validation needed for patient-reported outcome measures in CV research

Better criteria, validation needed for patient-reported outcome measures in CV research

An analysis of 50 patient-reported outcome measures used for CV outcomes trials shows most do not have validated psychometric properties recommended by the FDA and lack established minimally important differences, researchers reported.

News
September 18, 2022
3 min read
Save

Routine ultrasound improved femoral access; did not lower bleeding, vascular complications

Routine ultrasound improved femoral access; did not lower bleeding, vascular complications

BOSTON — Ultrasound-guided femoral access improved first attempt success in coronary procedures but did not reduce the occurrence of major bleeding and vascular complications vs. fluoroscopy alone, a speaker reported.

News
June 26, 2022
2 min read
Save

In type 2 diabetes, ‘something brain-friendly’ about GLP-1 receptor agonists

In type 2 diabetes, ‘something brain-friendly’ about GLP-1 receptor agonists

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker.

News
June 17, 2022
1 min read
Save

ATLAS

ATLAS

Assessing major perioperative, lead-related complications in subcutaneous vs. transvenous ICD.

News
June 08, 2022
2 min read
Save

Some older women with luminal A breast cancer can safely forgo radiotherapy, study shows

Some older women with luminal A breast cancer can safely forgo radiotherapy, study shows

CHICAGO — Patients aged 55 years or older with low-grade luminal A breast cancer who receive endocrine therapy can safely avoid radiotherapy after breast-conserving surgery, according to a prospective study presented at ASCO Annual Meeting.

View more